Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$996M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$397M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$362M |
| 4 |
Comcast
CMCSA
|
+$312M |
| 5 |
DuPont de Nemours
DD
|
+$262M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$6.3B |
| 2 |
Linde
LIN
|
+$1.26B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.07B |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$485M |
Sector Composition
| 1 | Technology | 20.46% |
| 2 | Financials | 10.38% |
| 3 | Consumer Discretionary | 9.4% |
| 4 | Healthcare | 9.13% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LEVL
3226
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $67K | ﹤0.01% |
4,010
+1,855
| +86% | +$31K |
|
|
ENBL
3227
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $67K | ﹤0.01% |
14,346
-467,101
| -97% | -$2.18M |
|
|
I
3228
DELISTED
INTELSAT S. A.
I
| $67K | ﹤0.01% |
122,747
+20,006
| +19% | +$10.9K |
|
3229
BioLife Solutions
BLFS
$1.28B
| $66K | ﹤0.01% |
4,018
+1,577
| +65% | +$25.9K |
|
3230
Intellicheck
IDN
$110M
| $66K | ﹤0.01% |
+8,757
| New | +$66K |
|
3231
Vanguard Small-Cap ETF
VB
$67.7B
| $66K | ﹤0.01% |
+450
| New | +$66K |
|
3232
Vanguard Mid-Cap ETF
VO
$88.4B
| $66K | ﹤0.01% |
+400
| New | +$66K |
|
|
JNCE
3233
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $66K | ﹤0.01% |
9,536
+3,945
| +71% | +$27.3K |
|
|
GCAP
3234
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $66K | ﹤0.01% |
10,982
+4,584
| +72% | +$27.5K |
|
3235
Townsquare Media
TSQ
$115M
| $65K | ﹤0.01% |
+14,544
| New | +$65K |
|
3236
Xoma
XOMA
$449M
| $65K | ﹤0.01% |
+3,326
| New | +$65K |
|
|
IIN
3237
DELISTED
IntriCon Corporation
IIN
| $65K | ﹤0.01% |
4,769
+2,033
| +74% | +$27.7K |
|
3238
Astria Therapeutics
ATXS
$434M
| $64K | ﹤0.01% |
+1,652
| New | +$64K |
|
3239
Evolus
EOLS
$477M
| $64K | ﹤0.01% |
12,019
+5,883
| +96% | +$31.3K |
|
3240
Farmer Brothers
FARM
$47.9M
| $64K | ﹤0.01% |
8,812
+5,256
| +148% | +$38.2K |
|
3241
Galectin Therapeutics
GALT
$375M
| $64K | ﹤0.01% |
21,051
+7,669
| +57% | +$23.3K |
|
3242
Geospace Technologies
GEOS
$213M
| $64K | ﹤0.01% |
8,469
-2,654
| -24% | -$20.1K |
|
3243
Gilat Satellite Networks
GILT
$624M
| $64K | ﹤0.01% |
10,000
-172
| -2% | -$1.1K |
|
3244
GSI Technology
GSIT
$95.1M
| $64K | ﹤0.01% |
8,854
+3,569
| +68% | +$25.8K |
|
3245
Hawthorn Bancshares
HWBK
$222M
| $64K | ﹤0.01% |
3,657
+1,462
| +67% | +$25.6K |
|
3246
Orion Energy Systems
OESX
$31.6M
| $64K | ﹤0.01% |
+1,862
| New | +$64K |
|
3247
Organogenesis Holdings
ORGO
$636M
| $64K | ﹤0.01% |
16,447
+7,151
| +77% | +$27.8K |
|
3248
ProQR Therapeutics
PRQR
$223M
| $64K | ﹤0.01% |
10,488
+7,135
| +213% | +$43.5K |
|
3249
SB Financial Group
SBFG
$136M
| $64K | ﹤0.01% |
+4,060
| New | +$64K |
|
3250
Stratus Properties
STRS
$160M
| $64K | ﹤0.01% |
3,237
+1,291
| +66% | +$25.5K |
|